世界のヒト用ワクチン市場予測2023-2029:水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン

【英語タイトル】Human Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2479)・商品コード:MMG23FB2479
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のヒト用ワクチン市場規模と予測を収録しています。・世界のヒト用ワクチン市場:売上、2018年-2023年、2024年-2029年
・世界のヒト用ワクチン市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト用ワクチン市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「水痘」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト用ワクチンのグローバル主要企業は、CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biologicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、ヒト用ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト用ワクチン市場:タイプ別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場:タイプ別市場シェア、2022年
・水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン

世界のヒト用ワクチン市場:用途別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場:用途別市場シェア、2022年
・大人、子供

世界のヒト用ワクチン市場:地域・国別、2018年-2023年、2024年-2029年
世界のヒト用ワクチン市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト用ワクチンのグローバル売上、2018年-2023年
・主要企業におけるヒト用ワクチンのグローバル売上シェア、2022年
・主要企業におけるヒト用ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるヒト用ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biological

*************************************************************

・調査・分析レポートの概要
ヒト用ワクチン市場の定義
市場セグメント
世界のヒト用ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト用ワクチン市場規模
世界のヒト用ワクチン市場規模:2022年 VS 2029年
世界のヒト用ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト用ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト用ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン
ヒト用ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:大人、子供
ヒト用ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト用ワクチン市場規模 2022年と2029年
地域別ヒト用ワクチン売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
CNBG、Changsheng Life、Zhifei、ChengDa Bio、Kangtai、SINOVAC BIOTECH、Hissen、Walvax Biotechnology、GSK、SANOFI、Rong An、NuoCheng Bio、Hualan Bio、Tiantan biological、Changchun Baike、Adimmune、Zhongyianke Biotech、Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Indian Immunologicals、KANGH、Henan Grand Biopharma、ZhongKe Biopharm、Zhuoyi Biological

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccine Overall Market Size
2.1 Global Human Vaccine Market Size: 2022 VS 2029
2.2 Global Human Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Human Vaccine Players in Global Market
3.2 Top Global Human Vaccine Companies Ranked by Revenue
3.3 Global Human Vaccine Revenue by Companies
3.4 Global Human Vaccine Sales by Companies
3.5 Global Human Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Vaccine Market Size Markets, 2022 & 2029
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, Tetanus
4.1.10 Pneumococcal
4.1.11 Rota vaccine
4.2 By Type – Global Human Vaccine Revenue & Forecasts
4.2.1 By Type – Global Human Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Human Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Human Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Human Vaccine Sales & Forecasts
4.3.1 By Type – Global Human Vaccine Sales, 2018-2023
4.3.2 By Type – Global Human Vaccine Sales, 2024-2029
4.3.3 By Type – Global Human Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Vaccine Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application – Global Human Vaccine Revenue & Forecasts
5.2.1 By Application – Global Human Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Human Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Human Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Human Vaccine Sales & Forecasts
5.3.1 By Application – Global Human Vaccine Sales, 2018-2023
5.3.2 By Application – Global Human Vaccine Sales, 2024-2029
5.3.3 By Application – Global Human Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Human Vaccine Revenue & Forecasts
6.2.1 By Region – Global Human Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Human Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Human Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Human Vaccine Sales & Forecasts
6.3.1 By Region – Global Human Vaccine Sales, 2018-2023
6.3.2 By Region – Global Human Vaccine Sales, 2024-2029
6.3.3 By Region – Global Human Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Human Vaccine Sales, 2018-2029
6.4.3 US Human Vaccine Market Size, 2018-2029
6.4.4 Canada Human Vaccine Market Size, 2018-2029
6.4.5 Mexico Human Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Human Vaccine Sales, 2018-2029
6.5.3 Germany Human Vaccine Market Size, 2018-2029
6.5.4 France Human Vaccine Market Size, 2018-2029
6.5.5 U.K. Human Vaccine Market Size, 2018-2029
6.5.6 Italy Human Vaccine Market Size, 2018-2029
6.5.7 Russia Human Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Human Vaccine Market Size, 2018-2029
6.5.9 Benelux Human Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Human Vaccine Sales, 2018-2029
6.6.3 China Human Vaccine Market Size, 2018-2029
6.6.4 Japan Human Vaccine Market Size, 2018-2029
6.6.5 South Korea Human Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Human Vaccine Market Size, 2018-2029
6.6.7 India Human Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Human Vaccine Sales, 2018-2029
6.7.3 Brazil Human Vaccine Market Size, 2018-2029
6.7.4 Argentina Human Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Vaccine Sales, 2018-2029
6.8.3 Turkey Human Vaccine Market Size, 2018-2029
6.8.4 Israel Human Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Human Vaccine Market Size, 2018-2029
6.8.6 UAE Human Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CNBG
7.1.1 CNBG Company Summary
7.1.2 CNBG Business Overview
7.1.3 CNBG Human Vaccine Major Product Offerings
7.1.4 CNBG Human Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CNBG Key News & Latest Developments
7.2 Changsheng Life
7.2.1 Changsheng Life Company Summary
7.2.2 Changsheng Life Business Overview
7.2.3 Changsheng Life Human Vaccine Major Product Offerings
7.2.4 Changsheng Life Human Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Changsheng Life Key News & Latest Developments
7.3 Zhifei
7.3.1 Zhifei Company Summary
7.3.2 Zhifei Business Overview
7.3.3 Zhifei Human Vaccine Major Product Offerings
7.3.4 Zhifei Human Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zhifei Key News & Latest Developments
7.4 ChengDa Bio
7.4.1 ChengDa Bio Company Summary
7.4.2 ChengDa Bio Business Overview
7.4.3 ChengDa Bio Human Vaccine Major Product Offerings
7.4.4 ChengDa Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 ChengDa Bio Key News & Latest Developments
7.5 Kangtai
7.5.1 Kangtai Company Summary
7.5.2 Kangtai Business Overview
7.5.3 Kangtai Human Vaccine Major Product Offerings
7.5.4 Kangtai Human Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Kangtai Key News & Latest Developments
7.6 SINOVAC BIOTECH
7.6.1 SINOVAC BIOTECH Company Summary
7.6.2 SINOVAC BIOTECH Business Overview
7.6.3 SINOVAC BIOTECH Human Vaccine Major Product Offerings
7.6.4 SINOVAC BIOTECH Human Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 SINOVAC BIOTECH Key News & Latest Developments
7.7 Hissen
7.7.1 Hissen Company Summary
7.7.2 Hissen Business Overview
7.7.3 Hissen Human Vaccine Major Product Offerings
7.7.4 Hissen Human Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Hissen Key News & Latest Developments
7.8 Walvax Biotechnology
7.8.1 Walvax Biotechnology Company Summary
7.8.2 Walvax Biotechnology Business Overview
7.8.3 Walvax Biotechnology Human Vaccine Major Product Offerings
7.8.4 Walvax Biotechnology Human Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Walvax Biotechnology Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Human Vaccine Major Product Offerings
7.9.4 GSK Human Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 GSK Key News & Latest Developments
7.10 SANOFI
7.10.1 SANOFI Company Summary
7.10.2 SANOFI Business Overview
7.10.3 SANOFI Human Vaccine Major Product Offerings
7.10.4 SANOFI Human Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 SANOFI Key News & Latest Developments
7.11 Rong An
7.11.1 Rong An Company Summary
7.11.2 Rong An Human Vaccine Business Overview
7.11.3 Rong An Human Vaccine Major Product Offerings
7.11.4 Rong An Human Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Rong An Key News & Latest Developments
7.12 NuoCheng Bio
7.12.1 NuoCheng Bio Company Summary
7.12.2 NuoCheng Bio Human Vaccine Business Overview
7.12.3 NuoCheng Bio Human Vaccine Major Product Offerings
7.12.4 NuoCheng Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 NuoCheng Bio Key News & Latest Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Company Summary
7.13.2 Hualan Bio Human Vaccine Business Overview
7.13.3 Hualan Bio Human Vaccine Major Product Offerings
7.13.4 Hualan Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Hualan Bio Key News & Latest Developments
7.14 Tiantan biological
7.14.1 Tiantan biological Company Summary
7.14.2 Tiantan biological Business Overview
7.14.3 Tiantan biological Human Vaccine Major Product Offerings
7.14.4 Tiantan biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Tiantan biological Key News & Latest Developments
7.15 Changchun Baike
7.15.1 Changchun Baike Company Summary
7.15.2 Changchun Baike Business Overview
7.15.3 Changchun Baike Human Vaccine Major Product Offerings
7.15.4 Changchun Baike Human Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Changchun Baike Key News & Latest Developments
7.16 Adimmune
7.16.1 Adimmune Company Summary
7.16.2 Adimmune Business Overview
7.16.3 Adimmune Human Vaccine Major Product Offerings
7.16.4 Adimmune Human Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Adimmune Key News & Latest Developments
7.17 Zhongyianke Biotech
7.17.1 Zhongyianke Biotech Company Summary
7.17.2 Zhongyianke Biotech Business Overview
7.17.3 Zhongyianke Biotech Human Vaccine Major Product Offerings
7.17.4 Zhongyianke Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Zhongyianke Biotech Key News & Latest Developments
7.18 Bharat Biotech
7.18.1 Bharat Biotech Company Summary
7.18.2 Bharat Biotech Business Overview
7.18.3 Bharat Biotech Human Vaccine Major Product Offerings
7.18.4 Bharat Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Bharat Biotech Key News & Latest Developments
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Company Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Human Vaccine Major Product Offerings
7.19.4 Bavarian Nordic Human Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Bavarian Nordic Key News & Latest Developments
7.20 Sanofi-Pasteur
7.20.1 Sanofi-Pasteur Company Summary
7.20.2 Sanofi-Pasteur Business Overview
7.20.3 Sanofi-Pasteur Human Vaccine Major Product Offerings
7.20.4 Sanofi-Pasteur Human Vaccine Sales and Revenue in Global (2018-2023)
7.20.5 Sanofi-Pasteur Key News & Latest Developments
7.21 Indian Immunologicals
7.21.1 Indian Immunologicals Company Summary
7.21.2 Indian Immunologicals Business Overview
7.21.3 Indian Immunologicals Human Vaccine Major Product Offerings
7.21.4 Indian Immunologicals Human Vaccine Sales and Revenue in Global (2018-2023)
7.21.5 Indian Immunologicals Key News & Latest Developments
7.22 KANGH
7.22.1 KANGH Company Summary
7.22.2 KANGH Business Overview
7.22.3 KANGH Human Vaccine Major Product Offerings
7.22.4 KANGH Human Vaccine Sales and Revenue in Global (2018-2023)
7.22.5 KANGH Key News & Latest Developments
7.23 Henan Grand Biopharma
7.23.1 Henan Grand Biopharma Company Summary
7.23.2 Henan Grand Biopharma Business Overview
7.23.3 Henan Grand Biopharma Human Vaccine Major Product Offerings
7.23.4 Henan Grand Biopharma Human Vaccine Sales and Revenue in Global (2018-2023)
7.23.5 Henan Grand Biopharma Key News & Latest Developments
7.24 ZhongKe Biopharm
7.24.1 ZhongKe Biopharm Company Summary
7.24.2 ZhongKe Biopharm Business Overview
7.24.3 ZhongKe Biopharm Human Vaccine Major Product Offerings
7.24.4 ZhongKe Biopharm Human Vaccine Sales and Revenue in Global (2018-2023)
7.24.5 ZhongKe Biopharm Key News & Latest Developments
7.25 Zhuoyi Biological
7.25.1 Zhuoyi Biological Company Summary
7.25.2 Zhuoyi Biological Business Overview
7.25.3 Zhuoyi Biological Human Vaccine Major Product Offerings
7.25.4 Zhuoyi Biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.25.5 Zhuoyi Biological Key News & Latest Developments
8 Global Human Vaccine Production Capacity, Analysis
8.1 Global Human Vaccine Production Capacity, 2018-2029
8.2 Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccine Supply Chain Analysis
10.1 Human Vaccine Industry Value Chain
10.2 Human Vaccine Upstream Market
10.3 Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Vaccine in Global Market
Table 2. Top Human Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Human Vaccine Sales by Companies, (M Doses), 2018-2023
Table 6. Global Human Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Human Vaccine Product Type
Table 9. List of Global Tier 1 Human Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Vaccine Sales (M Doses), 2018-2023
Table 15. By Type - Global Human Vaccine Sales (M Doses), 2024-2029
Table 16. By Application – Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Vaccine Sales (M Doses), 2018-2023
Table 20. By Application - Global Human Vaccine Sales (M Doses), 2024-2029
Table 21. By Region – Global Human Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Vaccine Sales (M Doses), 2018-2023
Table 25. By Region - Global Human Vaccine Sales (M Doses), 2024-2029
Table 26. By Country - North America Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Vaccine Sales, (M Doses), 2018-2023
Table 29. By Country - North America Human Vaccine Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Vaccine Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Human Vaccine Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Vaccine Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Human Vaccine Sales, (M Doses), 2024-2029
Table 38. By Country - South America Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Vaccine Sales, (M Doses), 2018-2023
Table 41. By Country - South America Human Vaccine Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Vaccine Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Human Vaccine Sales, (M Doses), 2024-2029
Table 46. CNBG Company Summary
Table 47. CNBG Human Vaccine Product Offerings
Table 48. CNBG Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. CNBG Key News & Latest Developments
Table 50. Changsheng Life Company Summary
Table 51. Changsheng Life Human Vaccine Product Offerings
Table 52. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Changsheng Life Key News & Latest Developments
Table 54. Zhifei Company Summary
Table 55. Zhifei Human Vaccine Product Offerings
Table 56. Zhifei Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Zhifei Key News & Latest Developments
Table 58. ChengDa Bio Company Summary
Table 59. ChengDa Bio Human Vaccine Product Offerings
Table 60. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. ChengDa Bio Key News & Latest Developments
Table 62. Kangtai Company Summary
Table 63. Kangtai Human Vaccine Product Offerings
Table 64. Kangtai Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Kangtai Key News & Latest Developments
Table 66. SINOVAC BIOTECH Company Summary
Table 67. SINOVAC BIOTECH Human Vaccine Product Offerings
Table 68. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. SINOVAC BIOTECH Key News & Latest Developments
Table 70. Hissen Company Summary
Table 71. Hissen Human Vaccine Product Offerings
Table 72. Hissen Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Hissen Key News & Latest Developments
Table 74. Walvax Biotechnology Company Summary
Table 75. Walvax Biotechnology Human Vaccine Product Offerings
Table 76. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Walvax Biotechnology Key News & Latest Developments
Table 78. GSK Company Summary
Table 79. GSK Human Vaccine Product Offerings
Table 80. GSK Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. GSK Key News & Latest Developments
Table 82. SANOFI Company Summary
Table 83. SANOFI Human Vaccine Product Offerings
Table 84. SANOFI Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. SANOFI Key News & Latest Developments
Table 86. Rong An Company Summary
Table 87. Rong An Human Vaccine Product Offerings
Table 88. Rong An Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Rong An Key News & Latest Developments
Table 90. NuoCheng Bio Company Summary
Table 91. NuoCheng Bio Human Vaccine Product Offerings
Table 92. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. NuoCheng Bio Key News & Latest Developments
Table 94. Hualan Bio Company Summary
Table 95. Hualan Bio Human Vaccine Product Offerings
Table 96. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Hualan Bio Key News & Latest Developments
Table 98. Tiantan biological Company Summary
Table 99. Tiantan biological Human Vaccine Product Offerings
Table 100. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 101. Tiantan biological Key News & Latest Developments
Table 102. Changchun Baike Company Summary
Table 103. Changchun Baike Human Vaccine Product Offerings
Table 104. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 105. Changchun Baike Key News & Latest Developments
Table 106. Adimmune Company Summary
Table 107. Adimmune Human Vaccine Product Offerings
Table 108. Adimmune Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 109. Adimmune Key News & Latest Developments
Table 110. Zhongyianke Biotech Company Summary
Table 111. Zhongyianke Biotech Human Vaccine Product Offerings
Table 112. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 113. Zhongyianke Biotech Key News & Latest Developments
Table 114. Bharat Biotech Company Summary
Table 115. Bharat Biotech Human Vaccine Product Offerings
Table 116. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 117. Bharat Biotech Key News & Latest Developments
Table 118. Bavarian Nordic Company Summary
Table 119. Bavarian Nordic Human Vaccine Product Offerings
Table 120. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 121. Bavarian Nordic Key News & Latest Developments
Table 122. Sanofi-Pasteur Company Summary
Table 123. Sanofi-Pasteur Human Vaccine Product Offerings
Table 124. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 125. Sanofi-Pasteur Key News & Latest Developments
Table 126. Indian Immunologicals Company Summary
Table 127. Indian Immunologicals Human Vaccine Product Offerings
Table 128. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 129. Indian Immunologicals Key News & Latest Developments
Table 130. KANGH Company Summary
Table 131. KANGH Human Vaccine Product Offerings
Table 132. KANGH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 133. KANGH Key News & Latest Developments
Table 134. Henan Grand Biopharma Company Summary
Table 135. Henan Grand Biopharma Human Vaccine Product Offerings
Table 136. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 137. Henan Grand Biopharma Key News & Latest Developments
Table 138. ZhongKe Biopharm Company Summary
Table 139. ZhongKe Biopharm Human Vaccine Product Offerings
Table 140. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 141. ZhongKe Biopharm Key News & Latest Developments
Table 142. Zhuoyi Biological Company Summary
Table 143. Zhuoyi Biological Human Vaccine Product Offerings
Table 144. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 145. Zhuoyi Biological Key News & Latest Developments
Table 146. Human Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 147. Global Human Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 148. Global Human Vaccine Production by Region, 2018-2023 (M Doses)
Table 149. Global Human Vaccine Production by Region, 2024-2029 (M Doses)
Table 150. Human Vaccine Market Opportunities & Trends in Global Market
Table 151. Human Vaccine Market Drivers in Global Market
Table 152. Human Vaccine Market Restraints in Global Market
Table 153. Human Vaccine Raw Materials
Table 154. Human Vaccine Raw Materials Suppliers in Global Market
Table 155. Typical Human Vaccine Downstream
Table 156. Human Vaccine Downstream Clients in Global Market
Table 157. Human Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Vaccine Segment by Type in 2022
Figure 2. Human Vaccine Segment by Application in 2022
Figure 3. Global Human Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Vaccine Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccine Revenue in 2022
Figure 9. By Type - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Vaccine Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Vaccine Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Vaccine Sales Market Share, 2018-2029
Figure 23. US Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Vaccine Sales Market Share, 2018-2029
Figure 37. China Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Vaccine Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Human Vaccine by Region, 2022 VS 2029
Figure 54. Human Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のヒト用ワクチン市場予測2023-2029:水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン] (コード:MMG23FB2479)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒト用ワクチン市場予測2023-2029:水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆